CA3022294A1 - Methode et systeme de caracterisation d'affections cutanees - Google Patents
Methode et systeme de caracterisation d'affections cutanees Download PDFInfo
- Publication number
- CA3022294A1 CA3022294A1 CA3022294A CA3022294A CA3022294A1 CA 3022294 A1 CA3022294 A1 CA 3022294A1 CA 3022294 A CA3022294 A CA 3022294A CA 3022294 A CA3022294 A CA 3022294A CA 3022294 A1 CA3022294 A1 CA 3022294A1
- Authority
- CA
- Canada
- Prior art keywords
- kegg
- derived feature
- feature
- skin
- derived
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 175
- 244000005700 microbiome Species 0.000 claims abstract description 313
- 238000012512 characterization method Methods 0.000 claims abstract description 236
- 238000002560 therapeutic procedure Methods 0.000 claims abstract description 196
- 239000000203 mixture Substances 0.000 claims abstract description 114
- 238000012163 sequencing technique Methods 0.000 claims abstract description 29
- 238000011282 treatment Methods 0.000 claims abstract description 17
- 239000000463 material Substances 0.000 claims abstract description 10
- 241000894007 species Species 0.000 claims description 102
- 230000004060 metabolic process Effects 0.000 claims description 73
- 239000012472 biological sample Substances 0.000 claims description 53
- 238000012545 processing Methods 0.000 claims description 43
- 230000015572 biosynthetic process Effects 0.000 claims description 36
- 108090000623 proteins and genes Proteins 0.000 claims description 29
- 230000015556 catabolic process Effects 0.000 claims description 24
- 230000002068 genetic effect Effects 0.000 claims description 23
- 201000004624 Dermatitis Diseases 0.000 claims description 22
- 206010013786 Dry skin Diseases 0.000 claims description 22
- 238000006731 degradation reaction Methods 0.000 claims description 22
- 230000037336 dry skin Effects 0.000 claims description 22
- 241000894006 Bacteria Species 0.000 claims description 21
- 238000009258 post-therapy Methods 0.000 claims description 21
- 208000010668 atopic eczema Diseases 0.000 claims description 20
- 210000004761 scalp Anatomy 0.000 claims description 20
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 19
- 230000003321 amplification Effects 0.000 claims description 18
- 230000001737 promoting effect Effects 0.000 claims description 18
- 102000004169 proteins and genes Human genes 0.000 claims description 17
- 230000001225 therapeutic effect Effects 0.000 claims description 17
- 206010000496 acne Diseases 0.000 claims description 16
- 150000007523 nucleic acids Chemical class 0.000 claims description 16
- 235000018102 proteins Nutrition 0.000 claims description 16
- 206010034972 Photosensitivity reaction Diseases 0.000 claims description 15
- 241001156739 Actinobacteria <phylum> Species 0.000 claims description 14
- 238000004458 analytical method Methods 0.000 claims description 14
- 108020004707 nucleic acids Proteins 0.000 claims description 14
- 102000039446 nucleic acids Human genes 0.000 claims description 14
- 230000036211 photosensitivity Effects 0.000 claims description 14
- 230000004044 response Effects 0.000 claims description 14
- 241001148536 Bacteroides sp. Species 0.000 claims description 12
- 208000001840 Dandruff Diseases 0.000 claims description 11
- 241001112724 Lactobacillales Species 0.000 claims description 9
- 241000186429 Propionibacterium Species 0.000 claims description 9
- 230000001580 bacterial effect Effects 0.000 claims description 9
- 239000013598 vector Substances 0.000 claims description 9
- 241000192125 Firmicutes Species 0.000 claims description 8
- 241000191940 Staphylococcus Species 0.000 claims description 8
- 241000194017 Streptococcus Species 0.000 claims description 8
- 230000008859 change Effects 0.000 claims description 8
- 241000605059 Bacteroidetes Species 0.000 claims description 7
- 102000004190 Enzymes Human genes 0.000 claims description 7
- 108090000790 Enzymes Proteins 0.000 claims description 7
- 230000003993 interaction Effects 0.000 claims description 7
- 230000009466 transformation Effects 0.000 claims description 7
- 241000193833 Bacillales Species 0.000 claims description 6
- 241001081257 Erysipelotrichales Species 0.000 claims description 6
- 241001081259 Erysipelotrichia Species 0.000 claims description 6
- 241000295644 Staphylococcaceae Species 0.000 claims description 6
- 241001147693 Staphylococcus sp. Species 0.000 claims description 6
- 241000194018 Streptococcaceae Species 0.000 claims description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 6
- -1 cyanoamino Chemical group 0.000 claims description 6
- 238000010801 machine learning Methods 0.000 claims description 6
- 208000002874 Acne Vulgaris Diseases 0.000 claims description 5
- 241001046559 Marvinbryantia Species 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 5
- 239000012634 fragment Substances 0.000 claims description 5
- 230000000977 initiatory effect Effects 0.000 claims description 5
- 230000010076 replication Effects 0.000 claims description 5
- 230000011664 signaling Effects 0.000 claims description 5
- 230000032258 transport Effects 0.000 claims description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 4
- 241000099223 Alistipes sp. Species 0.000 claims description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 4
- 241000606215 Bacteroides vulgatus Species 0.000 claims description 4
- 241000186000 Bifidobacterium Species 0.000 claims description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 4
- 208000035473 Communicable disease Diseases 0.000 claims description 4
- 241000186216 Corynebacterium Species 0.000 claims description 4
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 claims description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 4
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 4
- 241001521757 Propionibacterium sp. Species 0.000 claims description 4
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 4
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 4
- 235000001014 amino acid Nutrition 0.000 claims description 4
- 229940024606 amino acid Drugs 0.000 claims description 4
- 150000001413 amino acids Chemical class 0.000 claims description 4
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 claims description 4
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 claims description 4
- 229910052799 carbon Inorganic materials 0.000 claims description 4
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 4
- 230000036267 drug metabolism Effects 0.000 claims description 4
- 230000037149 energy metabolism Effects 0.000 claims description 4
- JBKVHLHDHHXQEQ-UHFFFAOYSA-N epsilon-caprolactam Chemical compound O=C1CCCCCN1 JBKVHLHDHHXQEQ-UHFFFAOYSA-N 0.000 claims description 4
- 229930195729 fatty acid Natural products 0.000 claims description 4
- 239000000194 fatty acid Substances 0.000 claims description 4
- 150000004665 fatty acids Chemical class 0.000 claims description 4
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 claims description 4
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 claims description 4
- 230000037356 lipid metabolism Effects 0.000 claims description 4
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 claims description 4
- 230000004048 modification Effects 0.000 claims description 4
- 238000012986 modification Methods 0.000 claims description 4
- 230000029553 photosynthesis Effects 0.000 claims description 4
- 238000010672 photosynthesis Methods 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 230000019491 signal transduction Effects 0.000 claims description 4
- 229910052717 sulfur Inorganic materials 0.000 claims description 4
- 239000011593 sulfur Substances 0.000 claims description 4
- 238000003786 synthesis reaction Methods 0.000 claims description 4
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 4
- 238000013518 transcription Methods 0.000 claims description 4
- 230000035897 transcription Effects 0.000 claims description 4
- 238000013519 translation Methods 0.000 claims description 4
- 230000004102 tricarboxylic acid cycle Effects 0.000 claims description 4
- 229940088594 vitamin Drugs 0.000 claims description 4
- 239000011782 vitamin Substances 0.000 claims description 4
- 235000013343 vitamin Nutrition 0.000 claims description 4
- 229930003231 vitamin Natural products 0.000 claims description 4
- 241000909284 Acidaminococcaceae Species 0.000 claims description 3
- 241000701474 Alistipes Species 0.000 claims description 3
- 241001227086 Anaerostipes Species 0.000 claims description 3
- 241001013579 Anaerotruncus Species 0.000 claims description 3
- 241000606126 Bacteroidaceae Species 0.000 claims description 3
- 241000692822 Bacteroidales Species 0.000 claims description 3
- 241000606125 Bacteroides Species 0.000 claims description 3
- 241001141113 Bacteroidia Species 0.000 claims description 3
- 241001135755 Betaproteobacteria Species 0.000 claims description 3
- 241001495171 Bilophila Species 0.000 claims description 3
- 241001202853 Blautia Species 0.000 claims description 3
- 241001600148 Burkholderiales Species 0.000 claims description 3
- 108010078791 Carrier Proteins Proteins 0.000 claims description 3
- 241001112696 Clostridia Species 0.000 claims description 3
- 241001430149 Clostridiaceae Species 0.000 claims description 3
- 241001112695 Clostridiales Species 0.000 claims description 3
- 241000193403 Clostridium Species 0.000 claims description 3
- 241001464956 Collinsella Species 0.000 claims description 3
- 241001657523 Coriobacteriaceae Species 0.000 claims description 3
- 241001662464 Coriobacteriales Species 0.000 claims description 3
- 241000186031 Corynebacteriaceae Species 0.000 claims description 3
- 241001467894 Desulfovibrionaceae Species 0.000 claims description 3
- 241001571085 Desulfovibrionales Species 0.000 claims description 3
- 241001143779 Dorea Species 0.000 claims description 3
- 241000089032 Erysipelatoclostridium Species 0.000 claims description 3
- 241000609971 Erysipelotrichaceae Species 0.000 claims description 3
- 241001608234 Faecalibacterium Species 0.000 claims description 3
- 241000605980 Faecalibacterium prausnitzii Species 0.000 claims description 3
- 241000244332 Flavobacteriaceae Species 0.000 claims description 3
- 241001141128 Flavobacteriales Species 0.000 claims description 3
- 241000230562 Flavobacteriia Species 0.000 claims description 3
- 241000662772 Flavonifractor Species 0.000 claims description 3
- 241000192128 Gammaproteobacteria Species 0.000 claims description 3
- 241000089024 Intestinibacter Species 0.000 claims description 3
- 241001134638 Lachnospira Species 0.000 claims description 3
- 241001112693 Lachnospiraceae Species 0.000 claims description 3
- 241000909283 Negativicutes Species 0.000 claims description 3
- 241000785902 Odoribacter Species 0.000 claims description 3
- 241001607451 Oscillospiraceae Species 0.000 claims description 3
- 241000160321 Parabacteroides Species 0.000 claims description 3
- 241000606752 Pasteurellaceae Species 0.000 claims description 3
- 241000947860 Pasteurellales Species 0.000 claims description 3
- 241001464921 Phascolarctobacterium Species 0.000 claims description 3
- 241000692843 Porphyromonadaceae Species 0.000 claims description 3
- 241000605861 Prevotella Species 0.000 claims description 3
- 241000692844 Prevotellaceae Species 0.000 claims description 3
- 241000192142 Proteobacteria Species 0.000 claims description 3
- 241000202386 Pseudobutyrivibrio Species 0.000 claims description 3
- 241000692845 Rikenellaceae Species 0.000 claims description 3
- 241000605947 Roseburia Species 0.000 claims description 3
- 241000095588 Ruminococcaceae Species 0.000 claims description 3
- 241000192023 Sarcina Species 0.000 claims description 3
- 241000909295 Selenomonadales Species 0.000 claims description 3
- 241001136694 Subdoligranulum Species 0.000 claims description 3
- 241000123710 Sutterella Species 0.000 claims description 3
- 241000813827 Sutterellaceae Species 0.000 claims description 3
- 241000089063 Terrisporobacter Species 0.000 claims description 3
- 241001148134 Veillonella Species 0.000 claims description 3
- 241001430183 Veillonellaceae Species 0.000 claims description 3
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims description 3
- 235000018417 cysteine Nutrition 0.000 claims description 3
- 230000007613 environmental effect Effects 0.000 claims description 3
- 238000012417 linear regression Methods 0.000 claims description 3
- 239000012528 membrane Substances 0.000 claims description 3
- 230000001717 pathogenic effect Effects 0.000 claims description 3
- 230000037361 pathway Effects 0.000 claims description 3
- 230000009885 systemic effect Effects 0.000 claims description 3
- INAPMGSXUVUWAF-UHFFFAOYSA-L (2,3,4,5,6-pentahydroxycyclohexyl) phosphate Chemical compound OC1C(O)C(O)C(OP([O-])([O-])=O)C(O)C1O INAPMGSXUVUWAF-UHFFFAOYSA-L 0.000 claims description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims description 2
- XEQLFNPSYWZPOW-NUOYRARPSA-N (2r)-4-amino-n-[(1r,2s,3r,4r,5s)-5-amino-4-[(2r,3r,4r,5s,6r)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-2-hydroxycyclohexyl]-2-hydroxybutanamide Chemical compound O([C@@H]1[C@@H](N)C[C@H]([C@@H]([C@H]1O[C@@H]1[C@@H]([C@H](O)[C@@H](CO)O1)O)O)NC(=O)[C@H](O)CCN)[C@H]1O[C@H](CN)[C@@H](O)[C@H](O)[C@H]1N XEQLFNPSYWZPOW-NUOYRARPSA-N 0.000 claims description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 claims description 2
- 102000005416 ATP-Binding Cassette Transporters Human genes 0.000 claims description 2
- 108010006533 ATP-Binding Cassette Transporters Proteins 0.000 claims description 2
- 241000203809 Actinomycetales Species 0.000 claims description 2
- 102000014777 Adipokines Human genes 0.000 claims description 2
- 108010078606 Adipokines Proteins 0.000 claims description 2
- 241001135230 Alistipes putredinis Species 0.000 claims description 2
- 241000099174 Anaerostipes sp. Species 0.000 claims description 2
- 241000304886 Bacilli Species 0.000 claims description 2
- 241001674039 Bacteroides acidifaciens Species 0.000 claims description 2
- 241000217846 Bacteroides caccae Species 0.000 claims description 2
- 241000606124 Bacteroides fragilis Species 0.000 claims description 2
- 241001220441 Bacteroides plebeius Species 0.000 claims description 2
- 241001430332 Bifidobacteriaceae Species 0.000 claims description 2
- 241001655328 Bifidobacteriales Species 0.000 claims description 2
- 241000335561 Blautia faecis Species 0.000 claims description 2
- 241000028537 Blautia luti Species 0.000 claims description 2
- 241000772275 Blautia sp. Species 0.000 claims description 2
- 241000335560 Blautia stercoris Species 0.000 claims description 2
- 241001038648 Blautia wexlerae Species 0.000 claims description 2
- 229930183180 Butirosin Natural products 0.000 claims description 2
- 229930186147 Cephalosporin Natural products 0.000 claims description 2
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 claims description 2
- 241001262170 Collinsella aerofaciens Species 0.000 claims description 2
- 241000186249 Corynebacterium sp. Species 0.000 claims description 2
- 241001098119 Corynebacterium spheniscorum Species 0.000 claims description 2
- 241000918600 Corynebacterium ulcerans Species 0.000 claims description 2
- 241000186427 Cutibacterium acnes Species 0.000 claims description 2
- 241001464975 Cutibacterium granulosum Species 0.000 claims description 2
- 102000002004 Cytochrome P-450 Enzyme System Human genes 0.000 claims description 2
- 108010015742 Cytochrome P-450 Enzyme System Proteins 0.000 claims description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 2
- QNAYBMKLOCPYGJ-UWTATZPHSA-N D-alanine Chemical compound C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 claims description 2
- 101710160937 DNA replication protein Proteins 0.000 claims description 2
- 241001135761 Deltaproteobacteria Species 0.000 claims description 2
- 241001535083 Dialister Species 0.000 claims description 2
- 241001531200 Dorea formicigenerans Species 0.000 claims description 2
- 241000016537 Dorea longicatena Species 0.000 claims description 2
- 239000005792 Geraniol Substances 0.000 claims description 2
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 claims description 2
- 108010024636 Glutathione Proteins 0.000 claims description 2
- 239000004471 Glycine Substances 0.000 claims description 2
- 208000023105 Huntington disease Diseases 0.000 claims description 2
- 102000004310 Ion Channels Human genes 0.000 claims description 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims description 2
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims description 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 2
- 241001134642 Lachnospira pectinoschiza Species 0.000 claims description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 2
- 239000004472 Lysine Substances 0.000 claims description 2
- 102000003939 Membrane transport proteins Human genes 0.000 claims description 2
- 108090000301 Membrane transport proteins Proteins 0.000 claims description 2
- 102000005431 Molecular Chaperones Human genes 0.000 claims description 2
- 108010006519 Molecular Chaperones Proteins 0.000 claims description 2
- 102000007462 Molecular Motor Proteins Human genes 0.000 claims description 2
- 108010085191 Molecular Motor Proteins Proteins 0.000 claims description 2
- MSFSPUZXLOGKHJ-UHFFFAOYSA-N Muraminsaeure Natural products OC(=O)C(C)OC1C(N)C(O)OC(CO)C1O MSFSPUZXLOGKHJ-UHFFFAOYSA-N 0.000 claims description 2
- 229930193140 Neomycin Natural products 0.000 claims description 2
- 206010028980 Neoplasm Diseases 0.000 claims description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 2
- YJQPYGGHQPGBLI-UHFFFAOYSA-N Novobiocin Natural products O1C(C)(C)C(OC)C(OC(N)=O)C(O)C1OC1=CC=C(C(O)=C(NC(=O)C=2C=C(CC=C(C)C)C(O)=CC=2)C(=O)O2)C2=C1C YJQPYGGHQPGBLI-UHFFFAOYSA-N 0.000 claims description 2
- 241001135232 Odoribacter splanchnicus Species 0.000 claims description 2
- 241000606210 Parabacteroides distasonis Species 0.000 claims description 2
- 241000204306 Parabacteroides merdae Species 0.000 claims description 2
- 229930182555 Penicillin Natural products 0.000 claims description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 claims description 2
- 102000035195 Peptidases Human genes 0.000 claims description 2
- 108091005804 Peptidases Proteins 0.000 claims description 2
- 108010013639 Peptidoglycan Proteins 0.000 claims description 2
- 241001112692 Peptostreptococcaceae Species 0.000 claims description 2
- 102000003728 Peroxisome Proliferator-Activated Receptors Human genes 0.000 claims description 2
- 108090000029 Peroxisome Proliferator-Activated Receptors Proteins 0.000 claims description 2
- 241001464924 Phascolarctobacterium faecium Species 0.000 claims description 2
- 241000711849 Phascolarctobacterium sp. Species 0.000 claims description 2
- 108091000080 Phosphotransferase Proteins 0.000 claims description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims description 2
- 102000019337 Prenyltransferases Human genes 0.000 claims description 2
- 108050006837 Prenyltransferases Proteins 0.000 claims description 2
- 208000031951 Primary immunodeficiency Diseases 0.000 claims description 2
- 241001430313 Propionibacteriaceae Species 0.000 claims description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Chemical compound CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims description 2
- 102000004245 Proteasome Endopeptidase Complex Human genes 0.000 claims description 2
- 108090000708 Proteasome Endopeptidase Complex Proteins 0.000 claims description 2
- 102000001253 Protein Kinase Human genes 0.000 claims description 2
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 claims description 2
- 101710198868 Recombination and repair protein Proteins 0.000 claims description 2
- 208000006265 Renal cell carcinoma Diseases 0.000 claims description 2
- 241000398180 Roseburia intestinalis Species 0.000 claims description 2
- 241001394655 Roseburia inulinivorans Species 0.000 claims description 2
- 241000711837 Roseburia sp. Species 0.000 claims description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 2
- 229920002472 Starch Polymers 0.000 claims description 2
- 241000194022 Streptococcus sp. Species 0.000 claims description 2
- 241000302468 Streptococcus sp. BS35a Species 0.000 claims description 2
- 241000096522 Streptococcus sp. oral taxon G59 Species 0.000 claims description 2
- 241000194020 Streptococcus thermophilus Species 0.000 claims description 2
- 241001580973 Subdoligranulum variabile Species 0.000 claims description 2
- 229930006000 Sucrose Natural products 0.000 claims description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 2
- 241000644554 Sutterella stercoricanis Species 0.000 claims description 2
- 241000123713 Sutterella wadsworthensis Species 0.000 claims description 2
- 239000004098 Tetracycline Substances 0.000 claims description 2
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 claims description 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims description 2
- 239000004473 Threonine Substances 0.000 claims description 2
- 108091023040 Transcription factor Proteins 0.000 claims description 2
- 102000040945 Transcription factor Human genes 0.000 claims description 2
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims description 2
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 claims description 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 2
- 241001261005 Verrucomicrobia Species 0.000 claims description 2
- 241000607626 Vibrio cholerae Species 0.000 claims description 2
- 238000010521 absorption reaction Methods 0.000 claims description 2
- 230000006978 adaptation Effects 0.000 claims description 2
- 150000001348 alkyl chlorides Chemical class 0.000 claims description 2
- 230000037354 amino acid metabolism Effects 0.000 claims description 2
- 229940064734 aminobenzoate Drugs 0.000 claims description 2
- 206010002026 amyotrophic lateral sclerosis Diseases 0.000 claims description 2
- 239000000427 antigen Substances 0.000 claims description 2
- 108091007433 antigens Proteins 0.000 claims description 2
- 102000036639 antigens Human genes 0.000 claims description 2
- 229940114079 arachidonic acid Drugs 0.000 claims description 2
- 235000021342 arachidonic acid Nutrition 0.000 claims description 2
- 229940072107 ascorbate Drugs 0.000 claims description 2
- 235000010323 ascorbic acid Nutrition 0.000 claims description 2
- 239000011668 ascorbic acid Substances 0.000 claims description 2
- 230000033590 base-excision repair Effects 0.000 claims description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 2
- 229940000635 beta-alanine Drugs 0.000 claims description 2
- 229960002685 biotin Drugs 0.000 claims description 2
- 235000020958 biotin Nutrition 0.000 claims description 2
- 239000011616 biotin Substances 0.000 claims description 2
- 229950004527 butirosin Drugs 0.000 claims description 2
- 235000021258 carbohydrate absorption Nutrition 0.000 claims description 2
- 235000021257 carbohydrate digestion Nutrition 0.000 claims description 2
- 230000023852 carbohydrate metabolic process Effects 0.000 claims description 2
- 235000021256 carbohydrate metabolism Nutrition 0.000 claims description 2
- 239000003054 catalyst Substances 0.000 claims description 2
- 230000022131 cell cycle Effects 0.000 claims description 2
- 230000030833 cell death Effects 0.000 claims description 2
- 230000032823 cell division Effects 0.000 claims description 2
- 230000010261 cell growth Effects 0.000 claims description 2
- 230000009087 cell motility Effects 0.000 claims description 2
- 230000001413 cellular effect Effects 0.000 claims description 2
- 230000033077 cellular process Effects 0.000 claims description 2
- 230000005754 cellular signaling Effects 0.000 claims description 2
- 229940124587 cephalosporin Drugs 0.000 claims description 2
- 150000001780 cephalosporins Chemical class 0.000 claims description 2
- 230000035605 chemotaxis Effects 0.000 claims description 2
- 229930002875 chlorophyll Natural products 0.000 claims description 2
- 235000019804 chlorophyll Nutrition 0.000 claims description 2
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 claims description 2
- 210000000349 chromosome Anatomy 0.000 claims description 2
- 235000017471 coenzyme Q10 Nutrition 0.000 claims description 2
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 claims description 2
- 210000004292 cytoskeleton Anatomy 0.000 claims description 2
- 230000003247 decreasing effect Effects 0.000 claims description 2
- 210000002249 digestive system Anatomy 0.000 claims description 2
- 239000002158 endotoxin Substances 0.000 claims description 2
- 229940014144 folate Drugs 0.000 claims description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 2
- 235000019152 folic acid Nutrition 0.000 claims description 2
- 239000011724 folic acid Substances 0.000 claims description 2
- 229930182830 galactose Natural products 0.000 claims description 2
- 229940113087 geraniol Drugs 0.000 claims description 2
- 230000004110 gluconeogenesis Effects 0.000 claims description 2
- 229960003180 glutathione Drugs 0.000 claims description 2
- 230000037362 glycan biosynthesis Effects 0.000 claims description 2
- 230000037347 glycan metabolism Effects 0.000 claims description 2
- 150000002313 glycerolipids Chemical class 0.000 claims description 2
- 150000002327 glycerophospholipids Chemical class 0.000 claims description 2
- 230000034659 glycolysis Effects 0.000 claims description 2
- 150000002337 glycosamines Chemical class 0.000 claims description 2
- HHLFWLYXYJOTON-UHFFFAOYSA-N glyoxylic acid Chemical compound OC(=O)C=O HHLFWLYXYJOTON-UHFFFAOYSA-N 0.000 claims description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims description 2
- VVIUBCNYACGLLV-UHFFFAOYSA-N hypotaurine Chemical compound [NH3+]CCS([O-])=O VVIUBCNYACGLLV-UHFFFAOYSA-N 0.000 claims description 2
- 208000026278 immune system disease Diseases 0.000 claims description 2
- 230000010365 information processing Effects 0.000 claims description 2
- 230000003834 intracellular effect Effects 0.000 claims description 2
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims description 2
- 229960000310 isoleucine Drugs 0.000 claims description 2
- 150000002576 ketones Chemical class 0.000 claims description 2
- 229940087305 limonene Drugs 0.000 claims description 2
- 235000001510 limonene Nutrition 0.000 claims description 2
- AGBQKNBQESQNJD-UHFFFAOYSA-M lipoate Chemical compound [O-]C(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-M 0.000 claims description 2
- 235000019136 lipoic acid Nutrition 0.000 claims description 2
- 229920006008 lipopolysaccharide Polymers 0.000 claims description 2
- 230000009061 membrane transport Effects 0.000 claims description 2
- 208000030159 metabolic disease Diseases 0.000 claims description 2
- 230000037340 metabolism of cofactors and vitamins Effects 0.000 claims description 2
- 230000037344 metabolism of terpenoids and polyketides Effects 0.000 claims description 2
- 229930182817 methionine Natural products 0.000 claims description 2
- 230000033607 mismatch repair Effects 0.000 claims description 2
- 229960004927 neomycin Drugs 0.000 claims description 2
- 230000004770 neurodegeneration Effects 0.000 claims description 2
- 208000015122 neurodegenerative disease Diseases 0.000 claims description 2
- 229960003966 nicotinamide Drugs 0.000 claims description 2
- 235000005152 nicotinamide Nutrition 0.000 claims description 2
- 239000011570 nicotinamide Substances 0.000 claims description 2
- 235000001968 nicotinic acid Nutrition 0.000 claims description 2
- 239000011664 nicotinic acid Substances 0.000 claims description 2
- 230000003121 nonmonotonic effect Effects 0.000 claims description 2
- 238000010606 normalization Methods 0.000 claims description 2
- 229960002950 novobiocin Drugs 0.000 claims description 2
- YJQPYGGHQPGBLI-KGSXXDOSSA-N novobiocin Chemical compound O1C(C)(C)[C@H](OC)[C@@H](OC(N)=O)[C@@H](O)[C@@H]1OC1=CC=C(C(O)=C(NC(=O)C=2C=C(CC=C(C)C)C(O)=CC=2)C(=O)O2)C2=C1C YJQPYGGHQPGBLI-KGSXXDOSSA-N 0.000 claims description 2
- 239000002773 nucleotide Substances 0.000 claims description 2
- 125000003729 nucleotide group Chemical group 0.000 claims description 2
- 230000037360 nucleotide metabolism Effects 0.000 claims description 2
- 230000020520 nucleotide-excision repair Effects 0.000 claims description 2
- 230000010627 oxidative phosphorylation Effects 0.000 claims description 2
- 229940014662 pantothenate Drugs 0.000 claims description 2
- 235000019161 pantothenic acid Nutrition 0.000 claims description 2
- 239000011713 pantothenic acid Substances 0.000 claims description 2
- 229940049954 penicillin Drugs 0.000 claims description 2
- 230000004108 pentose phosphate pathway Effects 0.000 claims description 2
- 210000002824 peroxisome Anatomy 0.000 claims description 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims description 2
- 229930015704 phenylpropanoid Natural products 0.000 claims description 2
- 150000002995 phenylpropanoid derivatives Chemical class 0.000 claims description 2
- 150000003905 phosphatidylinositols Chemical class 0.000 claims description 2
- 102000020233 phosphotransferase Human genes 0.000 claims description 2
- 230000000243 photosynthetic effect Effects 0.000 claims description 2
- 229930000732 piperidine alkaloid Natural products 0.000 claims description 2
- 244000000003 plant pathogen Species 0.000 claims description 2
- 239000011148 porous material Substances 0.000 claims description 2
- 150000004032 porphyrins Chemical class 0.000 claims description 2
- 229940055019 propionibacterium acne Drugs 0.000 claims description 2
- 235000019833 protease Nutrition 0.000 claims description 2
- 230000012846 protein folding Effects 0.000 claims description 2
- 108060006633 protein kinase Proteins 0.000 claims description 2
- 230000004144 purine metabolism Effects 0.000 claims description 2
- 229930002371 pyridine alkaloid Natural products 0.000 claims description 2
- 150000003222 pyridines Chemical class 0.000 claims description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 2
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 claims description 2
- 230000008439 repair process Effects 0.000 claims description 2
- 229960002477 riboflavin Drugs 0.000 claims description 2
- 235000019192 riboflavin Nutrition 0.000 claims description 2
- 239000002151 riboflavin Substances 0.000 claims description 2
- 230000028706 ribosome biogenesis Effects 0.000 claims description 2
- 229930000044 secondary metabolite Natural products 0.000 claims description 2
- 230000028327 secretion Effects 0.000 claims description 2
- 230000028070 sporulation Effects 0.000 claims description 2
- 235000019698 starch Nutrition 0.000 claims description 2
- 239000008107 starch Substances 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims description 2
- 239000005720 sucrose Substances 0.000 claims description 2
- 229960003080 taurine Drugs 0.000 claims description 2
- 229960002180 tetracycline Drugs 0.000 claims description 2
- 229930101283 tetracycline Natural products 0.000 claims description 2
- 235000019364 tetracycline Nutrition 0.000 claims description 2
- 150000003522 tetracyclines Chemical class 0.000 claims description 2
- 235000019157 thiamine Nutrition 0.000 claims description 2
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 claims description 2
- 229960003495 thiamine Drugs 0.000 claims description 2
- 239000011721 thiamine Substances 0.000 claims description 2
- 229960002663 thioctic acid Drugs 0.000 claims description 2
- UZKQTCBAMSWPJD-UQCOIBPSSA-N trans-Zeatin Natural products OCC(/C)=C\CNC1=NC=NC2=C1N=CN2 UZKQTCBAMSWPJD-UQCOIBPSSA-N 0.000 claims description 2
- UZKQTCBAMSWPJD-FARCUNLSSA-N trans-zeatin Chemical compound OCC(/C)=C/CNC1=NC=NC2=C1N=CN2 UZKQTCBAMSWPJD-FARCUNLSSA-N 0.000 claims description 2
- XLRPYZSEQKXZAA-OCAPTIKFSA-N tropane Chemical compound C1CC[C@H]2CC[C@@H]1N2C XLRPYZSEQKXZAA-OCAPTIKFSA-N 0.000 claims description 2
- 229930004668 tropane alkaloid Natural products 0.000 claims description 2
- 201000008827 tuberculosis Diseases 0.000 claims description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 2
- 229940035936 ubiquinone Drugs 0.000 claims description 2
- 239000004474 valine Substances 0.000 claims description 2
- 229940118696 vibrio cholerae Drugs 0.000 claims description 2
- 229940011671 vitamin b6 Drugs 0.000 claims description 2
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 2
- 239000002676 xenobiotic agent Substances 0.000 claims description 2
- 229940023877 zeatin Drugs 0.000 claims description 2
- 102000018832 Cytochromes Human genes 0.000 claims 1
- 108010052832 Cytochromes Proteins 0.000 claims 1
- 230000008569 process Effects 0.000 description 60
- 230000006870 function Effects 0.000 description 34
- 239000006041 probiotic Substances 0.000 description 30
- 235000018291 probiotics Nutrition 0.000 description 30
- 230000000529 probiotic effect Effects 0.000 description 28
- 239000000523 sample Substances 0.000 description 22
- 238000005516 engineering process Methods 0.000 description 19
- 230000036541 health Effects 0.000 description 14
- 239000003814 drug Substances 0.000 description 11
- 241001515965 unidentified phage Species 0.000 description 11
- 230000002596 correlated effect Effects 0.000 description 10
- 239000000047 product Substances 0.000 description 10
- 238000013459 approach Methods 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 230000006872 improvement Effects 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 238000012549 training Methods 0.000 description 7
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 6
- 238000004422 calculation algorithm Methods 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 238000009826 distribution Methods 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 230000001747 exhibiting effect Effects 0.000 description 6
- 238000009472 formulation Methods 0.000 description 6
- 238000000746 purification Methods 0.000 description 6
- 208000027244 Dysbiosis Diseases 0.000 description 5
- 230000000875 corresponding effect Effects 0.000 description 5
- 230000007140 dysbiosis Effects 0.000 description 5
- 238000012544 monitoring process Methods 0.000 description 5
- 229920001542 oligosaccharide Polymers 0.000 description 5
- 238000003752 polymerase chain reaction Methods 0.000 description 5
- 241000736262 Microbiota Species 0.000 description 4
- 230000003542 behavioural effect Effects 0.000 description 4
- 238000004891 communication Methods 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 210000004209 hair Anatomy 0.000 description 4
- 244000005702 human microbiome Species 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 238000013507 mapping Methods 0.000 description 4
- 235000013406 prebiotics Nutrition 0.000 description 4
- 230000002441 reversible effect Effects 0.000 description 4
- 238000005070 sampling Methods 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- 230000000153 supplemental effect Effects 0.000 description 4
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 3
- 206010035043 Pilonidal cyst Diseases 0.000 description 3
- 208000003251 Pruritus Diseases 0.000 description 3
- 230000006399 behavior Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 238000003066 decision tree Methods 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 235000015872 dietary supplement Nutrition 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 description 3
- 230000036449 good health Effects 0.000 description 3
- 230000007803 itching Effects 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 238000002483 medication Methods 0.000 description 3
- 201000010153 skin papilloma Diseases 0.000 description 3
- 150000003384 small molecules Chemical class 0.000 description 3
- 238000007619 statistical method Methods 0.000 description 3
- 230000000699 topical effect Effects 0.000 description 3
- 238000000844 transformation Methods 0.000 description 3
- 230000001131 transforming effect Effects 0.000 description 3
- FVVCFHXLWDDRHG-UPLOTWCNSA-N (2s,3r,4s,5r,6r)-2-[(2r,3s,4r,5r,6r)-6-[(2s,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)[C@@H](CO)O1 FVVCFHXLWDDRHG-UPLOTWCNSA-N 0.000 description 2
- VOJUXHHACRXLTD-UHFFFAOYSA-N 1,4-dihydroxy-2-naphthoic acid Chemical compound C1=CC=CC2=C(O)C(C(=O)O)=CC(O)=C21 VOJUXHHACRXLTD-UHFFFAOYSA-N 0.000 description 2
- 108020004465 16S ribosomal RNA Proteins 0.000 description 2
- 108020004414 DNA Proteins 0.000 description 2
- 208000005373 Dyshidrotic Eczema Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 208000010305 Epidermal Cyst Diseases 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 208000007514 Herpes zoster Diseases 0.000 description 2
- 206010020649 Hyperkeratosis Diseases 0.000 description 2
- 238000007397 LAMP assay Methods 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 239000004909 Moisturizer Substances 0.000 description 2
- 206010034016 Paronychia Diseases 0.000 description 2
- 208000000528 Pilonidal Sinus Diseases 0.000 description 2
- 201000004681 Psoriasis Diseases 0.000 description 2
- 206010039792 Seborrhoea Diseases 0.000 description 2
- 206010039793 Seborrhoeic dermatitis Diseases 0.000 description 2
- 102000008579 Transposases Human genes 0.000 description 2
- 108010020764 Transposases Proteins 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 230000002421 anti-septic effect Effects 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 229940064004 antiseptic throat preparations Drugs 0.000 description 2
- 208000002399 aphthous stomatitis Diseases 0.000 description 2
- 229920000617 arabinoxylan Polymers 0.000 description 2
- 150000004783 arabinoxylans Chemical class 0.000 description 2
- 238000013473 artificial intelligence Methods 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 238000003287 bathing Methods 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 239000000090 biomarker Substances 0.000 description 2
- 210000000746 body region Anatomy 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000001332 colony forming effect Effects 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 210000003608 fece Anatomy 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 210000005260 human cell Anatomy 0.000 description 2
- 230000036571 hydration Effects 0.000 description 2
- 238000006703 hydration reaction Methods 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 238000007834 ligase chain reaction Methods 0.000 description 2
- 150000003272 mannan oligosaccharides Chemical class 0.000 description 2
- 210000004379 membrane Anatomy 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 230000001333 moisturizer Effects 0.000 description 2
- 231100001160 nonlethal Toxicity 0.000 description 2
- 230000037312 oily skin Effects 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 238000011338 personalized therapy Methods 0.000 description 2
- 230000008092 positive effect Effects 0.000 description 2
- 238000007637 random forest analysis Methods 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 208000008742 seborrheic dermatitis Diseases 0.000 description 2
- 239000002453 shampoo Substances 0.000 description 2
- 206010040882 skin lesion Diseases 0.000 description 2
- 231100000444 skin lesion Toxicity 0.000 description 2
- 239000007790 solid phase Substances 0.000 description 2
- 238000000528 statistical test Methods 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 230000002123 temporal effect Effects 0.000 description 2
- 230000003827 upregulation Effects 0.000 description 2
- VOJUXHHACRXLTD-UHFFFAOYSA-M 1,4-dihydroxy-2-naphthoate Chemical compound C1=CC=C2C(O)=CC(C([O-])=O)=C(O)C2=C1 VOJUXHHACRXLTD-UHFFFAOYSA-M 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 108010065780 2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase Proteins 0.000 description 1
- PVXPPJIGRGXGCY-TZLCEDOOSA-N 6-O-alpha-D-glucopyranosyl-D-fructofuranose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)C(O)(CO)O1 PVXPPJIGRGXGCY-TZLCEDOOSA-N 0.000 description 1
- PVXPPJIGRGXGCY-DJHAAKORSA-N 6-O-alpha-D-glucopyranosyl-alpha-D-fructofuranose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@](O)(CO)O1 PVXPPJIGRGXGCY-DJHAAKORSA-N 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 201000004625 Acrodermatitis Diseases 0.000 description 1
- 241000702460 Akkermansia Species 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 108091093088 Amplicon Proteins 0.000 description 1
- 229920000856 Amylose Polymers 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 241000193755 Bacillus cereus Species 0.000 description 1
- 241001328122 Bacillus clausii Species 0.000 description 1
- 241000193749 Bacillus coagulans Species 0.000 description 1
- 241000194108 Bacillus licheniformis Species 0.000 description 1
- 241001226430 Bacillus polyfermenticus Species 0.000 description 1
- 241000194103 Bacillus pumilus Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 206010004194 Bed bug infestation Diseases 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- 241000186016 Bifidobacterium bifidum Species 0.000 description 1
- 241000193764 Brevibacillus brevis Species 0.000 description 1
- 208000003643 Callosities Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 241000863012 Caulobacter Species 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 201000006082 Chickenpox Diseases 0.000 description 1
- 241001327638 Cimex lectularius Species 0.000 description 1
- 241000193171 Clostridium butyricum Species 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- 206010012442 Dermatitis contact Diseases 0.000 description 1
- 206010012444 Dermatitis diaper Diseases 0.000 description 1
- 206010012468 Dermatitis herpetiformis Diseases 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 208000003105 Diaper Rash Diseases 0.000 description 1
- 206010014190 Eczema asteatotic Diseases 0.000 description 1
- 244000148064 Enicostema verticillatum Species 0.000 description 1
- 241000520130 Enterococcus durans Species 0.000 description 1
- 241000194032 Enterococcus faecalis Species 0.000 description 1
- 241000194031 Enterococcus faecium Species 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010016936 Folliculitis Diseases 0.000 description 1
- 206010017543 Fungal skin infection Diseases 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 208000004898 Herpes Labialis Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 208000008017 Hypohidrosis Diseases 0.000 description 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
- 206010021531 Impetigo Diseases 0.000 description 1
- 208000002078 Ingrown Nails Diseases 0.000 description 1
- 206010052899 Ingrown hair Diseases 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- 208000007993 Kaposi Varicelliform Eruption Diseases 0.000 description 1
- 208000002260 Keloid Diseases 0.000 description 1
- 206010023330 Keloid scar Diseases 0.000 description 1
- 238000001276 Kolmogorov–Smirnov test Methods 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 240000001046 Lactobacillus acidophilus Species 0.000 description 1
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 description 1
- 240000001929 Lactobacillus brevis Species 0.000 description 1
- 235000013957 Lactobacillus brevis Nutrition 0.000 description 1
- 244000199866 Lactobacillus casei Species 0.000 description 1
- 235000013958 Lactobacillus casei Nutrition 0.000 description 1
- 241000186673 Lactobacillus delbrueckii Species 0.000 description 1
- 241000186840 Lactobacillus fermentum Species 0.000 description 1
- 241000186606 Lactobacillus gasseri Species 0.000 description 1
- 240000002605 Lactobacillus helveticus Species 0.000 description 1
- 235000013967 Lactobacillus helveticus Nutrition 0.000 description 1
- 241001468157 Lactobacillus johnsonii Species 0.000 description 1
- 240000006024 Lactobacillus plantarum Species 0.000 description 1
- 235000013965 Lactobacillus plantarum Nutrition 0.000 description 1
- 241000186604 Lactobacillus reuteri Species 0.000 description 1
- 241000186869 Lactobacillus salivarius Species 0.000 description 1
- 208000005230 Leg Ulcer Diseases 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 241000192130 Leuconostoc mesenteroides Species 0.000 description 1
- 238000007476 Maximum Likelihood Methods 0.000 description 1
- 108060004795 Methyltransferase Proteins 0.000 description 1
- 206010027626 Milia Diseases 0.000 description 1
- 206010028885 Necrotising fasciitis Diseases 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 201000009053 Neurodermatitis Diseases 0.000 description 1
- 208000025966 Neurological disease Diseases 0.000 description 1
- 206010054107 Nodule Diseases 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 206010067152 Oral herpes Diseases 0.000 description 1
- 206010033733 Papule Diseases 0.000 description 1
- 241000517307 Pediculus humanus Species 0.000 description 1
- 241000192001 Pediococcus Species 0.000 description 1
- 241000191996 Pediococcus pentosaceus Species 0.000 description 1
- 206010034277 Pemphigoid Diseases 0.000 description 1
- 241001674048 Phthiraptera Species 0.000 description 1
- 241000425347 Phyla <beetle> Species 0.000 description 1
- 208000004210 Pressure Ulcer Diseases 0.000 description 1
- 241001299661 Prevotella bryantii Species 0.000 description 1
- 241000219492 Quercus Species 0.000 description 1
- 238000011529 RT qPCR Methods 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- 206010037888 Rash pustular Diseases 0.000 description 1
- 229920000294 Resistant starch Polymers 0.000 description 1
- 240000003152 Rhus chinensis Species 0.000 description 1
- 235000014220 Rhus chinensis Nutrition 0.000 description 1
- 241001303601 Rosacea Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 206010039796 Seborrhoeic keratosis Diseases 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 241000204115 Sporolactobacillus inulinus Species 0.000 description 1
- 241000439819 Sporolactobacillus vineae Species 0.000 description 1
- 206010041736 Sporotrichosis Diseases 0.000 description 1
- 206010041955 Stasis dermatitis Diseases 0.000 description 1
- 244000057717 Streptococcus lactis Species 0.000 description 1
- 235000014897 Streptococcus lactis Nutrition 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 102000000591 Tight Junction Proteins Human genes 0.000 description 1
- 108010002321 Tight Junction Proteins Proteins 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 208000007712 Tinea Versicolor Diseases 0.000 description 1
- 206010056131 Tinea versicolour Diseases 0.000 description 1
- 241000159243 Toxicodendron radicans Species 0.000 description 1
- 241000893966 Trichophyton verrucosum Species 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 206010046980 Varicella Diseases 0.000 description 1
- 206010046996 Varicose vein Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 206010047642 Vitiligo Diseases 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 102000044820 Zonula Occludens-1 Human genes 0.000 description 1
- 108700007340 Zonula Occludens-1 Proteins 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 208000009621 actinic keratosis Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 208000002029 allergic contact dermatitis Diseases 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 229940054340 bacillus coagulans Drugs 0.000 description 1
- 229940104704 bacillus polyfermenticus Drugs 0.000 description 1
- 238000013542 behavioral therapy Methods 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- 229960003328 benzoyl peroxide Drugs 0.000 description 1
- 229940002008 bifidobacterium bifidum Drugs 0.000 description 1
- 238000003766 bioinformatics method Methods 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 235000020299 breve Nutrition 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000003196 chaotropic effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000000546 chi-square test Methods 0.000 description 1
- 230000035606 childbirth Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- 238000011281 clinical therapy Methods 0.000 description 1
- 230000001149 cognitive effect Effects 0.000 description 1
- 238000009226 cognitive therapy Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000010205 computational analysis Methods 0.000 description 1
- 238000000205 computational method Methods 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 238000005094 computer simulation Methods 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 208000005035 cutaneous candidiasis Diseases 0.000 description 1
- 201000010251 cutis laxa Diseases 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 210000004443 dendritic cell Anatomy 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 201000001981 dermatomyositis Diseases 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000021004 dietary regimen Nutrition 0.000 description 1
- 108010089355 dihydroneopterin aldolase Proteins 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 230000003828 downregulation Effects 0.000 description 1
- 208000013046 dyshidrosis Diseases 0.000 description 1
- 206010014197 eczema herpeticum Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 229940032049 enterococcus faecalis Drugs 0.000 description 1
- 208000017338 epidermoid cysts Diseases 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 210000003495 flagella Anatomy 0.000 description 1
- 238000007672 fourth generation sequencing Methods 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- 238000012252 genetic analysis Methods 0.000 description 1
- 238000012268 genome sequencing Methods 0.000 description 1
- 210000002175 goblet cell Anatomy 0.000 description 1
- 208000024963 hair loss Diseases 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 201000011066 hemangioma Diseases 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 238000007849 hot-start PCR Methods 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 206010021198 ichthyosis Diseases 0.000 description 1
- 201000002597 ichthyosis vulgaris Diseases 0.000 description 1
- 230000005965 immune activity Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 208000001875 irritant dermatitis Diseases 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 210000001117 keloid Anatomy 0.000 description 1
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 description 1
- 229960003451 lactitol Drugs 0.000 description 1
- 239000000832 lactitol Substances 0.000 description 1
- 235000010448 lactitol Nutrition 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 229940039695 lactobacillus acidophilus Drugs 0.000 description 1
- 229940017800 lactobacillus casei Drugs 0.000 description 1
- 229940012969 lactobacillus fermentum Drugs 0.000 description 1
- 229940054346 lactobacillus helveticus Drugs 0.000 description 1
- 229940072205 lactobacillus plantarum Drugs 0.000 description 1
- 229940001882 lactobacillus reuteri Drugs 0.000 description 1
- JCQLYHFGKNRPGE-FCVZTGTOSA-N lactulose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 JCQLYHFGKNRPGE-FCVZTGTOSA-N 0.000 description 1
- 229960000511 lactulose Drugs 0.000 description 1
- PFCRQPBOOFTZGQ-UHFFFAOYSA-N lactulose keto form Natural products OCC(=O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O PFCRQPBOOFTZGQ-UHFFFAOYSA-N 0.000 description 1
- 208000028454 lice infestation Diseases 0.000 description 1
- 201000011486 lichen planus Diseases 0.000 description 1
- 206010025135 lupus erythematosus Diseases 0.000 description 1
- 230000002934 lysing effect Effects 0.000 description 1
- 238000007403 mPCR Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 208000008588 molluscum contagiosum Diseases 0.000 description 1
- 235000013557 nattō Nutrition 0.000 description 1
- 201000007970 necrotizing fasciitis Diseases 0.000 description 1
- 238000007857 nested PCR Methods 0.000 description 1
- 238000007481 next generation sequencing Methods 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000007918 pathogenicity Effects 0.000 description 1
- 238000001558 permutation test Methods 0.000 description 1
- 239000007793 ph indicator Substances 0.000 description 1
- 208000002440 photoallergic dermatitis Diseases 0.000 description 1
- 208000007578 phototoxic dermatitis Diseases 0.000 description 1
- 231100000018 phototoxicity Toxicity 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 201000011414 pompholyx Diseases 0.000 description 1
- 208000029561 pustule Diseases 0.000 description 1
- 238000012175 pyrosequencing Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 210000003289 regulatory T cell Anatomy 0.000 description 1
- 235000021254 resistant starch Nutrition 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 201000004700 rosacea Diseases 0.000 description 1
- 229960002181 saccharomyces boulardii Drugs 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 235000015598 salt intake Nutrition 0.000 description 1
- 238000007480 sanger sequencing Methods 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 201000003779 seborrheic infantile dermatitis Diseases 0.000 description 1
- 201000003385 seborrheic keratosis Diseases 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000002864 sequence alignment Methods 0.000 description 1
- 238000002922 simulated annealing Methods 0.000 description 1
- 238000011125 single therapy Methods 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000000551 statistical hypothesis test Methods 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 208000003265 stomatitis Diseases 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000010119 systemic immune function Effects 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- BWMISRWJRUSYEX-SZKNIZGXSA-N terbinafine hydrochloride Chemical compound Cl.C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 BWMISRWJRUSYEX-SZKNIZGXSA-N 0.000 description 1
- 210000001578 tight junction Anatomy 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 238000007862 touchdown PCR Methods 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 208000027185 varicose disease Diseases 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
- G16B25/20—Polymerase chain reaction [PCR]; Primer or probe design; Probe optimisation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
- G16B40/20—Supervised data analysis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medical Informatics (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Data Mining & Analysis (AREA)
- Zoology (AREA)
- Theoretical Computer Science (AREA)
- Wood Science & Technology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Evolutionary Biology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Artificial Intelligence (AREA)
- Bioethics (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Databases & Information Systems (AREA)
- Epidemiology (AREA)
- Evolutionary Computation (AREA)
- Public Health (AREA)
- Software Systems (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Cette invention concerne des modes de réalisation d'une méthode et d'un système de caractérisation de l'affection cutanée d'un utilisateur pouvant comprendre un ou plusieurs des éléments suivants : un réseau de gestion servant à collecter des récipients contenant du matériel biologique provenant d'un ensemble d'utilisateurs, le réseau de gestion comprenant un système de séquençage pouvant être utilisé pour déterminer des séquences de micro-organismes par séquençage du matériel biologique; un système de caractérisation du microbiome servant à : déterminer des données de composition du microbiome et/ou des données de diversité fonctionnelle du microbiome en fonction des séquences des micro-organismes; recueillir des données supplémentaires associées à l'affection cutanée auprès de l'ensemble des utilisateurs et convertir ces données supplémentaires et les données de composition du microbiome et/ou les données de diversité fonctionnelle du microbiome en modèle de caractérisation; et un système à visée thérapeutique permettant de promouvoir un traitement de l'affection cutanée auprès de l'utilisateur en fonction de la caractérisation de l'utilisateur obtenue à l'aide du modèle de caractérisation lié à son affection cutanée.
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662327126P | 2016-04-25 | 2016-04-25 | |
US201662327048P | 2016-04-25 | 2016-04-25 | |
US201662327089P | 2016-04-25 | 2016-04-25 | |
US62/327,126 | 2016-04-25 | ||
US62/327,089 | 2016-04-25 | ||
US62/327,048 | 2016-04-25 | ||
PCT/US2017/029470 WO2017189614A1 (fr) | 2016-04-25 | 2017-04-25 | Méthode et système de caractérisation d'affections cutanées |
Publications (1)
Publication Number | Publication Date |
---|---|
CA3022294A1 true CA3022294A1 (fr) | 2017-11-02 |
Family
ID=60160002
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA3022294A Pending CA3022294A1 (fr) | 2016-04-25 | 2017-04-25 | Methode et systeme de caracterisation d'affections cutanees |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP3448399A4 (fr) |
CN (1) | CN109152803B (fr) |
AU (1) | AU2017257785A1 (fr) |
CA (1) | CA3022294A1 (fr) |
WO (1) | WO2017189614A1 (fr) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2016528880A (ja) | 2013-06-18 | 2016-09-23 | プロダームアイキュー インコーポレイテッド | 皮膚細菌叢の解析に基づくカスタマイズしたスキンケア製品及びパーソナルケア製品 |
CN109803673A (zh) | 2016-09-13 | 2019-05-24 | 阿勒根公司 | 非蛋白质梭菌毒素组合物 |
KR20200019116A (ko) | 2017-03-10 | 2020-02-21 | 프로더믹, 인코포레이티드 | 피부 균총의 분석에 기반한 맞춤형 피부 케어 제품 및 개인 케어 제품 |
JP2021519096A (ja) * | 2018-03-26 | 2021-08-10 | プロダームアイキュー,インク. | ざ瘡を処置するための組成物および方法 |
AU2019242894A1 (en) * | 2018-03-29 | 2020-10-22 | Kimberly-Clark Worldwide, Inc. | Sensor for indicating a potential forthcoming skin or gastrointestinal issue and methods of using the same |
EP4367259A1 (fr) * | 2021-07-05 | 2024-05-15 | Unilever IP Holdings B.V. | Procédé d'évaluation d'une composition cosmétique ou d'un composant de celle-ci |
CN117597454A (zh) * | 2021-07-05 | 2024-02-23 | 联合利华知识产权控股有限公司 | 用于评估皮肤的方法 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012098238A1 (fr) * | 2011-01-21 | 2012-07-26 | Novimmune S.A. | Associations thérapeutiques et méthodes d'utilisation d'agents modulateurs anti-cd3 et d'antagonistes anti-il-6 |
CN107936121B (zh) * | 2011-05-16 | 2022-01-14 | 埃泰美德(香港)有限公司 | 多特异性fab融合蛋白及其使用方法 |
JP2015512255A (ja) * | 2012-03-17 | 2015-04-27 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | ざ瘡の高速診断および個人化された治療 |
US10131710B2 (en) * | 2013-01-14 | 2018-11-20 | Xencor, Inc. | Optimized antibody variable regions |
WO2014131711A1 (fr) * | 2013-02-26 | 2014-09-04 | Roche Glycart Ag | Molécules bispécifiques de liaison à l'antigène activant les lymphocytes t |
DK2968552T3 (da) * | 2013-03-14 | 2020-04-14 | Scripps Research Inst | Targeteringsmiddel-antistofkonjugater og anvendelser deraf |
JP2016528880A (ja) * | 2013-06-18 | 2016-09-23 | プロダームアイキュー インコーポレイテッド | 皮膚細菌叢の解析に基づくカスタマイズしたスキンケア製品及びパーソナルケア製品 |
CN105829589B (zh) * | 2013-11-07 | 2021-02-02 | 小利兰·斯坦福大学理事会 | 用于分析人体微生物组及其组分的无细胞核酸 |
AU2015209718B2 (en) * | 2014-01-25 | 2021-03-25 | Psomagen, Inc. | Method and system for microbiome analysis |
EP3209803A4 (fr) * | 2014-10-21 | 2018-06-13 | Ubiome, Inc. | Procédé et système de diagnostic et de thérapie fondés sur le microbiome |
AU2016250100A1 (en) * | 2015-04-13 | 2017-11-09 | Psomagen, Inc. | Method and system for microbiome-derived characterization, diagnostics and therapeutics for cutaneous conditions |
WO2017156031A1 (fr) * | 2016-03-07 | 2017-09-14 | uBiome, Inc. | Procédé et système de caractérisation d'états pathologiques associés à la bouche |
-
2017
- 2017-04-25 EP EP17790288.9A patent/EP3448399A4/fr active Pending
- 2017-04-25 CA CA3022294A patent/CA3022294A1/fr active Pending
- 2017-04-25 WO PCT/US2017/029470 patent/WO2017189614A1/fr active Application Filing
- 2017-04-25 AU AU2017257785A patent/AU2017257785A1/en active Pending
- 2017-04-25 CN CN201780030413.6A patent/CN109152803B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
WO2017189614A1 (fr) | 2017-11-02 |
EP3448399A1 (fr) | 2019-03-06 |
EP3448399A4 (fr) | 2020-05-13 |
CN109152803B (zh) | 2022-09-23 |
AU2017257785A1 (en) | 2018-11-08 |
CN109152803A (zh) | 2019-01-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10169541B2 (en) | Method and systems for characterizing skin related conditions | |
US10381117B2 (en) | Method and system for microbiome-derived characterization, diagnostics and therapeutics for cutaneous conditions | |
US10327641B2 (en) | Method and system for microbiome-derived characterization, diagnostics and therapeutics for conditions associated with functional features | |
US10786195B2 (en) | Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with mircrobiome taxonomic features | |
US10787714B2 (en) | Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with microbiome functional features | |
US10366793B2 (en) | Method and system for characterizing microorganism-related conditions | |
US10246753B2 (en) | Method and system for characterizing mouth-associated conditions | |
US10381112B2 (en) | Method and system for characterizing allergy-related conditions associated with microorganisms | |
CA3022294A1 (fr) | Methode et systeme de caracterisation d'affections cutanees | |
AU2016321349A1 (en) | Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with gastrointestinal health | |
US20170235902A1 (en) | Method and system for characterization of clostridium difficile associated conditions | |
AU2022200243A1 (en) | Method and system for microbiome-derived characterization, diagnostics and therapeutics for cutaneous conditions | |
AU2016366656A1 (en) | Method and system for characterization of Clostridium difficile-associated conditions | |
WO2018112459A1 (fr) | Procédé et système destinés à la caractérisation d'états pathologiques apparentés à un microorganisme | |
EP3775257A1 (fr) | Procédé et système pour caractériser des affections liées à une allergie et associées à des micro-organismes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request |
Effective date: 20211129 |
|
EEER | Examination request |
Effective date: 20211129 |
|
EEER | Examination request |
Effective date: 20211129 |
|
EEER | Examination request |
Effective date: 20211129 |
|
EEER | Examination request |
Effective date: 20211129 |
|
EEER | Examination request |
Effective date: 20211129 |